Merz Therapeutics – Startup Investor Profile

General Info

Merz Therapeutics is dedicated to improve the lives of patients in the field of neurotoxins.
Location: Frankfurt
Country:
Industries:
Investment Regions: EU
Investment Stages: late-stage, seed, series-a

corporate-vc
EU

Want to start building warm intros with this investor?

Get Started for Free

🤖 AI Activity Report

Status: not-active

AI Reasoning: Search found a Merz Therapeutics investment in startup Vensica with press release dated February 7, 2022. No more recent investor activity (investment in startups) was found in 2023-2025; more recent Merz Therapeutics news relates to asset purchases in 2024 (acquisitions of drugs) which are corporate acquisitions rather than startup investments. The last known startup investment (Vensica) occurred over 3 years ago, which is more than 12 months ago; the duration since that investment aligns with the ‘not-active’ threshold.

Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.

Warm Intros from Portfolio Companies


Founder

Founder

Founder

Founder

Founder

Investment Regions Map

loading map…

Similar Investors

Region match

Albert Wright

Based on Region
Stage match

Risto Siilasmaa

Based on Stage
Vertical match

Norges Bank

Based on Industry
Other similar investors:

Latest on X (Twitter)



Access all contact details of Merz Therapeutics

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.

Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.

Trusted by Founders like You

Find your matching investors using AI

Sign up to EasyVC